ResMed to Announce First Quarter Fiscal Year 2018 Results

SAN DIEGO, Sept. 28, 2017 /PRNewswire/ -- ResMed (NYSE: RMD) today announced it will report its first quarter of fiscal year 2018 results on Thursday, October 26, 2017, after the New York Stock Exchange market closes. A press release with ResMed's results will be issued after 1:00 p.m. US Pacific Time and the company will host a webcast to discuss operating results and future outlook.

The earnings webcast is scheduled to begin at 1:30 p.m. US Pacific Time and the live webcast of the call can be accessed on ResMed's Investor Relations website at Please go to this section of the website and click on the icon for the "Q1 2018 earnings webcast."

Please note that we do not use outside phone lines to access the earnings call.

International earnings webcast times will be:

Thursday, October 26, 9:30 p.m.      


Friday, October 27, 7:30 a.m.            


A replay of the earnings webcast will be accessible on our website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately two hours after the webcast and will be accessible from October 26, 2017, until November 9, 2017, at:


+1 800-585-8367

Outside US:   

+1 416-621-4642



About ResMed
ResMed (NYSE: RMD) changes lives with award-winning medical devices and cutting-edge cloud-based software applications that better diagnose, treat and manage sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed is a global leader in connected care, with more than 3 million patients remotely monitored every day. Our 6,000-strong team is committed to creating the world's best tech-driven medical device company – improving quality of life, reducing the impact of chronic disease, and saving healthcare costs in more than 120 countries. ResMed.comFacebookTwitter | LinkedIn.

For media

For investors

Alison Graves

Agnes Lee

+1 858-836-6789 

+1 858-836-5971


ResMed Inc. logo. (PRNewsFoto/ResMed Inc.)


View original content with multimedia:

SOURCE ResMed Inc.